The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. - Wikidata - wikimedia - TriplyDB

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

http://www.wikidata.org/entity/Q51188122

about

Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit Central venous catheter (CVC) removal for adult patients with candidaemia Central venous catheter (CVC) removal for patients of all ages with candidaemia Imaging fungal infections in children Database Research for Pediatric Infectious Diseases Interleukin 17-Mediated Host Defense against Candida albicans Emerging drugs and vaccines for candidemia Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents New insights into innate immune control of systemic candidiasis Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later Risk prediction for invasive candidiasis Identification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophages Structure of Protein Geranylgeranyltransferase-I from the Human Pathogen Candida albicans Complexed with a Lipid Substrate Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1 PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90 Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin Hsp90 governs dispersion and drug resistance of fungal biofilms Development of a high-throughput Candida albicans biofilm chip Mapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitry Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species Epidemiology of invasive candidiasis: a persistent public health problem Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.Hospital epidemiology and infection control in acute-care settings.Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study Prevalence of fungal infections using National Health Insurance data from 2009-2013, South Korea.Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia Saccharomyces cerevisiae: population divergence and resistance to oxidative stress in clinical, domesticated and wild isolates Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study.Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity.Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.Candida infections of the genitourinary tract.In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infections Incidence and predictors of invasive candidiasis associated with candidaemia in children.Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.

P2860

Q21194915-563567EF-CDB7-4B63-AA11-222029C43CA0 Q24195090-0D4933CA-8AD3-4C33-AABB-6CD9BE84DBCE Q26471135-343DCEE2-3496-4E9C-A02F-0BE7B20AE652 Q26766376-8FB1FB9D-2E06-4C30-B411-3EDA1B164FE8 Q26781065-ADADF87F-910E-4118-90BB-07219F97EB6E Q26798127-2B46EEDC-F9B0-458F-84F3-385627B4AAB4 Q26828993-C117CA99-F1CE-423D-B63A-7F6A4D589FED Q26863344-9740A4D6-1DB8-45F3-9F58-CCDA86026B6B Q27002519-39D69B89-FCE6-4E1A-86C8-4AAF2F4DDDB8 Q27012454-A4083C6A-CFE8-4DA7-9045-6A0142BDB7EF Q27023082-42D1FA1B-6C7B-4294-8AC9-2AAE4F030C5B Q27335258-E4CA8C53-1A1A-404E-94DC-CAF1A54EDC0C Q27651678-FF6BD7E3-A4D4-48F0-961E-6D212F051D3E Q28109664-4D79BF1A-018E-46BB-872C-3D1BF97F967A Q28471781-289E470F-5AB7-4235-B28F-543EECCD3D24 Q28475333-B3F59C83-F144-4BB7-80C4-2E2106FE8FCE Q28475818-13632F6C-B73F-4EAD-ACAF-033B39BEC3DB Q28476836-5BA12EC3-B568-4BE6-BB37-A88BD59C5C47 Q28477874-C23B74E5-C460-483F-AC5A-D8E2300F8C84 Q28481516-CE259435-3811-4A4D-B901-6D0517AA5AE3 Q28483785-D50387CB-0703-438B-891C-A618873A572D Q28740362-7D4F0708-5952-4C4B-8934-4F2FC25E4E7B Q28830609-FA0D2981-37EC-407E-8470-E88637AB0E9B Q29616758-86AF46DA-0BE4-4472-8945-44AC4145FAEC Q30300387-B061725F-275B-4E80-96CA-396F1C204E5C Q30429049-230459C5-58E5-46CA-91B7-75741BCF8EB5 Q30781344-2C949CB0-1470-4BA8-874D-ECA4B75921C6 Q30865768-AB305F50-F052-40E7-84A2-CE29A4328A56 Q33265510-760DEF69-D454-4D75-AE46-2F2352DFB9C7 Q33434488-08DDD479-4D9D-41C9-8F4B-1EC6D092B1AE Q33595137-A3047B42-8EFF-4EBA-BA1D-C983412FEBF8 Q33602928-C28D23BB-CE44-4E72-95F0-86234C3C71CE Q33603993-DDD4B78F-AE11-4BA7-9CB7-8472297F5C34 Q33683476-744CA7E9-F208-4720-936B-7E82B21AB490 Q33816237-B61D03AB-B26B-40C4-B3C0-B2B2A4D715BC Q33825621-1C50AC17-64FD-4C2B-ADEC-E304241B77AD Q33851255-AAEB05B9-BA91-4730-9C8C-0461C57E3AA1 Q33926760-CCC2765D-943D-4B3D-98BA-568BF25C15E5 Q34006585-CDB5340F-4577-43E4-84D5-1EB256B9F19E Q34036214-9724C9C5-62D1-4958-A86D-0C49FD6F7184

P2860

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

http://www.wikidata.org/entity/Q51188122

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

The epidemiology and attributa ...... States: a propensity analysis.

@en

The epidemiology and attributa ...... States: a propensity analysis.

@nl

type

label

The epidemiology and attributa ...... States: a propensity analysis.

@en

The epidemiology and attributa ...... States: a propensity analysis.

@nl

prefLabel

The epidemiology and attributa ...... States: a propensity analysis.

@en

The epidemiology and attributa ...... States: a propensity analysis.

@nl

P1433

Q51188122-F975361C-0DCE-482C-BB98-BEE538497B09

P1476

Q51188122-9ECC0996-2845-4314-B41F-91A335F6EE13

P2093

Q51188122-04913720-C23E-4B13-BB5D-25051BB92ED5

Q51188122-1579BD70-4021-4706-A6D2-0C4B826FDDD1

Q51188122-6EF73AA1-10AC-4E4B-AEB7-D9789FD7BE27

Q51188122-7CE121FE-30BC-4830-852A-8B96B5965F6A

Q51188122-8C934D88-583C-4B7F-B047-167F6A742153

Q51188122-D8C8A022-C6F4-4C2B-89F7-2208BA97E496

P2860

Q51188122-14766130-2BF3-41A1-9170-2F194F379C7B

Q51188122-1664BB24-E26F-4C08-B20E-3AB298795505

Q51188122-189FCC06-39D2-4B92-B166-92CC7C846EA4

Q51188122-194379F7-11BE-4280-A18E-C26D43401FD1

Q51188122-1C9D26AC-9E25-403F-BE61-2EA32BA3BA8C

Q51188122-1DB74E66-B6C1-4E1B-9E4F-14ACCD988CBD

Q51188122-33079823-4E3B-441A-86CA-AE3D585B3B28

Q51188122-42508635-3285-4FC9-BAFA-8C203B33844F

Q51188122-609AD4E0-17CF-4E1B-9440-218B7D632329

Q51188122-659BD462-B72D-4AAC-8F49-B8924BC52388

P304

Q51188122-CFE3EF19-410C-425B-9DC7-8F90A6F44249

P31

Q51188122-F63D8150-65AA-468C-B8F5-FF1875F9585C

P356

Q51188122-A04AF9DF-4A75-4787-8288-C40A2E7E1DBE

P407

Q51188122-36257AE8-82A1-47EF-BEDD-C6A28945311A

P433

Q51188122-A3C71667-A9FE-46F6-9AC1-E7050A421631

P478

Q51188122-0D782B41-D996-4037-9BAD-8328AD34D537

P577

Q51188122-81D1149F-7C3F-4A1D-BD9E-0DDDFAA884A2

P5875

Q51188122-87777F34-BF0A-434B-B651-B256410383C1

P698

Q51188122-3CE2E591-C327-45DB-9CA2-9BFDEC959AAA

P921

Q51188122-0FBB89DE-08B5-45AF-AAA4-06AD15C51B9E

P356

P1433

Clinical Infectious Diseases

P1476

The epidemiology and attributa ...... States: a propensity analysis.

@en

P2093

Chris Feudtner

http://www.w3.org/2001/XMLSchema#string

Jaclyn Chu

http://www.w3.org/2001/XMLSchema#string

Jesse A Berlin

http://www.w3.org/2001/XMLSchema#string

Jesse Argon

http://www.w3.org/2001/XMLSchema#string

Theoklis E Zaoutis

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

The epidemiology of sepsis in the United States from 1979 through 2000

Influenza-associated hospitalizations in the United States

Fluconazole prophylaxis against fungal colonization and infection in preterm infants.

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Improved outcomes of children with malignancy admitted to a pediatric intensive care unit.

Prophylactic antifungal therapy in the intensive care unit.

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery

Risk factors for disseminated candidiasis in children with candidemia.

P304

1232-1239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/496922

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7559522

http://www.w3.org/2001/XMLSchema#string

P698

16206095

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization